In the study of Lefere et al., serum angiopoietin-2 levels were elevated in MASH patients and correlated with liver steatosis, inflammation, and hepatocyte ballooning but not with liver fibrosis [36]. The gene discussed is ANGPT2; the disease is metabolic dysfunction-associated steatohepatitis.